Derudas, D. Guest Editor: Pellegrino Musto HOW FIRST-LINE THERAPY IS CHANGING IN NON-TRANSPLANT ELIGIBLE MULTIPLE MYELOMA PATIENTS. Mediterr J Hematol Infect Dis 2025, 17, e2025025.